Low molecular weight heparins have the following
advantages over unfractionated heparin except:
A. Higher efficacy in arterial thrombosis
B. Less frequent dosing
C. Higher and more consistent subcutaneous
bioavailability
D. Laboratory monitoring of response not
required
advantages over unfractionated heparin except:
A. Higher efficacy in arterial thrombosis
B. Less frequent dosing
C. Higher and more consistent subcutaneous
bioavailability
D. Laboratory monitoring of response not
required